6505--F18 - Flutemetamol - Flyrcado

Justification and Approval (J&A) for Other Than Full and Open Competition

This document justifies the Department of Veterans Affairs (VA) Network Contracting Office 17 (NCO-17) intending to award a new firm-fixed-price contract with Medi-Physics, Inc. for the procurement of Flyrcado™™ (flurpiridaz F-18) Injection. This is for other than full and open competition.

• Procurement of Flyrcado™™ (flurpiridaz F-18) Injection.

• Estimated annual quantity: 675 mCi.

• The drug is a radioactive diagnostic agent for Positron Emission Tomography (PET) myocardial perfusion imaging (MPI) to evaluate for myocardial ischemia and infarction.

• Contract Type: Firm-fixed-price.

• Ordering Periods: Five (5) one-year ordering periods.

• Total Estimated Value: $1,288,946.25.

• Delivery Dates: March 2, 2026 – March 1, 2031.

• This is a justification for sole source procurement, not a solicitation for proposals.

• A notice of intent was posted to SAM Contract Opportunities on January 6, 2026, and no responses were received.

• The justification cites "Only One Responsible Source" as the authority for other than full and open competition.

• Market research did not identify any small businesses that offer Flyrcado™™.

• GE Healthcare, the manufacturer of Flyrcado™™, states that it is only available through GE Healthcare or their radiopharmacy partners.

• The Buy American Act is applicable, and radiopharmaceuticals are manufactured in the US.

• Market research was conducted from August 29, 2025, through January 14, 2026.

Solicitation / RFP / RFQ

This document is a synopsis for the procurement of F18 - Flutemetamol - Flyrcado. The Department of Veterans Affairs, Network Contracting Office 17, is seeking offers for this product.

• The specific product service code is 6505.

• The North American Industry Classification System (NAICS) code is 325412 (Pharmaceutical and Medicine Manufacturing).

• The solicitation number is 36C25726Q0205.

• The award number associated with this opportunity is 36C25726D0056.

• The award amount is $0.00.

• The award date was March 10, 2026.

• The awardee was MEDI-PHYSICS, INC. (UEI: CETPVZL5RQS3).

• Not explicitly detailed in the provided metadata, but the solicitation number indicates a formal procurement process.

• Not specified in the provided metadata.

• The contracting office is located in San Antonio, TX (ZIP code 78240).

• The Point of Contact is Vance Farrell, Contract Specialist, at vance.farrell@va.gov.

• The document references an attached document: '36C257-26-AP-0992-FY26-1695 JOFOC NCO17 Flyrcado - HCA Approved -'.

Solicitation / RFP / RFQ

This document appears to be related to a previous award for "Flyrcado F18 Flurpiridaz Radiopharmaceutical Injection." The provided text includes award details rather than a solicitation. Therefore, a summary of a solicitation cannot be generated from this input.

N/A

• Award Number: 36C25726P0222
• Award Amount: $378,090.90
• Line Item Number: 0001
• Award Date: 02-10-2026
• Awardee Name: MEDI-PHYSICS, INC.
• Contractor's UEI: CETPVZL5RQS3
• Awardee Address: 3350 N RIDGE AVE, ARLINGTON HEIGHTS, IL 60004

N/A

N/A

• Product Service Code: 6505
• NAICS Code: 325412
• Contracting Office: Department Of Veterans Affairs, Network Contracting Office 17, San Antonio TX 78240
• Point of Contact: Vance Farrell (vance.farrell@va.gov)
• Description: Refers to an attached document: JA - Part 806.3 - Over SAT - 36C257-26-AP-1108 - Redacted.

Justification and Approval (J&A) for Other Than Full and Open Competition

This document justifies the Department of Veterans Affairs (VA) Network Contracting Office 17 (NCO-17) intending to award a firm-fixed price contract with Medi-Physics, Inc. for the procurement of Flyrcado™™ (flurpiridaz F-18) Injection. This justification is for other than full and open competition.

• Procurement of Flyrcado™™ (flurpiridaz F-18) Injection.

• Quantity: 990 mCi.

• The drug is indicated for positron emission tomography (PET) myocardial perfusion imaging (MPI) under rest or stress to evaluate for myocardial ischemia and infarction in patients with known or suspected coronary artery disease (CAD).

• Contract Type: Firm-fixed price.

• Estimated Total Value: $378,090.90.

• Period of Performance: Delivery Dates: 2/10/2026 – 2/9/2027.

This document is a justification for sole source procurement, not a solicitation. A notice of intent was posted to SAM Contract Opportunities on 1/5/2026, and no responses were received.

This action is being justified for other than full and open competition under 41 USC §3304(a)(1) as implemented by RFO 6.103-1, citing only one responsible source.

• Medi-Physics, Inc. (doing business as GE Healthcare) is the sole manufacturer of Flyrcado™™.
• Market research confirmed that mandatory sources (UNICOR, Ability One) do not offer radiopharmaceuticals, GSA Advantage did not list the item, and the VA NAC catalog only lists it on GE Healthcare's FSS contract. A search for small businesses offering Flyrcado™™ was unsuccessful.
• The Contracting Officer anticipates the cost will be fair and reasonable, based on typical pricing offered by Medi-Physics, Inc. in VA pharmaceutical contracts.

Solicitation / RFP / RFQ

This is a Presolicitation Notice announcing the Department of Veterans Affairs' intent to award a sole source contract for Flyrcado™ (flurpiridaz F-18) Injection. The procurement is intended for the VA North Texas Health Care System and South Texas Veterans Health Care System.

• Item: Flyrcado™ (flurpiridaz F-18) Injection

• Unit of Issue: EA (mCi)

• Quantity: 990

• Contract Type: Firm-fixed priced

• Pricing: Based on GE Healthcare's VA NAC contract 36F79725D0214.

• Awardee: Medi-Physics, Inc.

• Notice Type: This is not a request for quotations or proposals. No contract will be awarded based solely on responses to this notice.

• Capability Statement: Interested parties may submit a capability statement, proposal, or quotation to determine if a comparable and more advantageous source exists.

• Response Deadline: Within 7 days from the publication of this notice.

• Action if No Response: If no affirmative written response is received, a contract or order will be issued to Cardinal Health without further notice.

• Authority: The proposed sole source procurement is under 41 U.S.C. 3304(a)(1), implemented by FAR 6.302-1, due to only one responsible source satisfying agency requirements.

• Product Service Code: 6505

• NAICS Code: 325412

• Solicitation Number: 36C25726Q0205

• Response Date: January 12, 2026, 3:00 PM Central Time, Chicago, USA.

• Contact: Vance Farrell, Contract Specialist, vance.farrell@va.gov